Literature DB >> 2946891

Immune complex induced glomerular lesions in C5 sufficient and deficient mice.

R J Falk, J C Jennette.   

Abstract

The role in the pathogenesis of immune complex-mediated glomerulonephritis of C5 or some terminal complement component dependent upon C5 for activation was explored in a congenic strain of C5 sufficient (NSN) and C5 deficient (OSN) mice. When these mice were given daily injections of heterologous protein, horse apoferritin (HAF), there were profound differences between the strains in the development of glomerulonephritis and renal dysfunction. When NSN and OSN mice produced low levels of anti-HAF, NSN mice developed extensive glomerular deposits of HAF and immune reactants and a mild proliferative glomerulonephritis. In contrast, comparable OSN mice developed only trace mesangial localization of HAF and no glomerular lesions by light microscopy. When NSN and OSN mice produced high levels of anti-HAF, both strains had equivalent glomerular immune deposits; however, NSN mice developed a severe necrotizing and crescentic glomerulonephritis, while OSN mice had much less glomerular injury. Compared to OSN mice, these NSN mice also had much more severe tubulointerstitial injury, and significantly higher serum creatinine levels. Thus, in this experimental model, the absence of C5 resulted in reduced glomerular immune complex localization when there were small amounts of circulating immune reactants; and in markedly reduced glomerular leukocyte influx, necrosis and crescent formation, when large amounts of immune reactants have localized in glomeruli. These effects could be mediated by C5 (such as C5a) or by some terminal complement component(s) dependent upon C5 for activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2946891     DOI: 10.1038/ki.1986.240

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Complement gene expression in hepatic and extrahepatic tissues of NZB and NZB x W (F1) mouse strains.

Authors:  J H Passwell; G F Schreiner; R A Wetsel; H R Colten
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

2.  Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.

Authors:  P J Baker; R F Ochi; M Schulze; R J Johnson; C Campbell; W G Couser
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

3.  C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis.

Authors:  T R Welch; M Frenzke; D Witte; A E Davis
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

4.  Development of antihuman IgG antibodies and hematologic deficits but not clinical abnormalities in C57BL/6 mice after repeated administration of human intravenous immunoglobulin.

Authors:  David A Loeffler; Lynnae M Smith; Andrea C Klaver; Heather A Brzezinski; Essie I Morrison; Mary P Coffey; Barbara A Steficek; Susan S Cook
Journal:  Comp Med       Date:  2012-02       Impact factor: 0.982

5.  Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.

Authors:  J C Jennette; R R Tidwell; J D Geratz; D H Bing; R J Falk
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

Review 6.  Complement regulation in renal disease models.

Authors:  Abhijit Naik; Shweta Sharma; Richard J Quigg
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

7.  Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor.

Authors:  Jessy J Alexander; Lee D Chaves; Anthony Chang; Shruti Dighe; Alexander Jacob; Richard J Quigg
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

8.  The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.

Authors:  Jessy J Alexander; Lee Chaves; Anthony Chang; Richard J Quigg
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612

9.  Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.

Authors:  R J Quigg; C He; A Lim; D Berthiaume; J J Alexander; D Kraus; V M Holers
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.